找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Management of Renal Tumors; Ronald M. Bukowski,Andrew C. Novick Book 2008 The Editor(s) (if applicable) and The Author(s), under

[復(fù)制鏈接]
樓主: POL
11#
發(fā)表于 2025-3-23 13:47:41 | 只看該作者
Radical Nephrectomy,, and a lymph node dissection, removing the paraaortic and paracaval nodal packets from the crus of the diaphragm superiorly to the aortic bifurcation inferiorly. Since that time, the technique of radical nephrectomy has undergone some modification, but the general principles outlined remain germane to today’s contemporary practice.
12#
發(fā)表于 2025-3-23 14:12:47 | 只看該作者
13#
發(fā)表于 2025-3-23 20:13:44 | 只看該作者
14#
發(fā)表于 2025-3-24 01:59:18 | 只看該作者
th renal cancer having localized or advanced disease are discussed. Surgical approaches for primary and metastatic tumors, symptom palliation, and systemic therapy for metastatic disease including immunotherapy and targeted approaches are discussed in detail..978-1-60761-469-2978-1-60327-149-3
15#
發(fā)表于 2025-3-24 05:41:00 | 只看該作者
https://doi.org/10.1007/978-3-642-88120-6s and experimental studies. Furthermore, pathologists could allocate any redundant tumor tissues not required for diagnosis to basic research programs. Pathologists, urologists, and other clinicians play equally important roles in the optimal handling and processing of renal cell carcinoma specimens.
16#
發(fā)表于 2025-3-24 09:32:14 | 只看該作者
17#
發(fā)表于 2025-3-24 14:14:06 | 只看該作者
Probleme der Sch?deldachplastikradiologic data will be of importance to validate results if a surrogate endpoint such as disease free survival is utilized. In view of our current knowledge of the biology of clear cell carcinoma, studies utiling medications such as sunitinib, sorafenib, or bevacizumab are considerations.
18#
發(fā)表于 2025-3-24 18:17:02 | 只看該作者
19#
發(fā)表于 2025-3-24 20:11:09 | 只看該作者
20#
發(fā)表于 2025-3-25 01:57:43 | 只看該作者
Adjuvant Therapy of Renal Cell Carcinoma,radiologic data will be of importance to validate results if a surrogate endpoint such as disease free survival is utilized. In view of our current knowledge of the biology of clear cell carcinoma, studies utiling medications such as sunitinib, sorafenib, or bevacizumab are considerations.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 01:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
乌恰县| 临澧县| 惠州市| 大荔县| 贵定县| 改则县| 岚皋县| 五河县| 芮城县| 香格里拉县| 惠水县| 隆林| 德江县| 宁城县| 邵武市| 阿坝县| 三门县| 铜梁县| 玉环县| 北碚区| 克山县| 阳江市| 葵青区| 邹城市| 汕尾市| 武夷山市| 垫江县| 分宜县| 新郑市| 新乐市| 敖汉旗| 波密县| 江西省| 育儿| 乐都县| 安新县| 将乐县| 衡阳县| 罗定市| 崇左市| 桐庐县|